Drug Profile
UCB 106607
Alternative Names: UCB-106607Latest Information Update: 21 Mar 2007
Price :
$50
*
At a glance
- Originator UCB
- Class Antidepressants
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Major depressive disorder
Most Recent Events
- 11 Oct 2006 Phase-I clinical trials in Depression in Belgium (unspecified route)